• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL2300877 重组抗CD20人源化单克隆抗体皮下注射液 Recombinant anti-CD20 humanized monoclonal antibody Injection Biological Products(1) New Drug Application 2023-12-22 Shanghai Shangyao Cross Linked Pharmaceutical Technology Co Ltd view
CXSL2300798 重组抗CD20人源化单克隆抗体皮下注射液 Recombinant anti-CD20 humanized monoclonal antibody Injection Biological Products(1) New Drug Application 2023-11-22 Shanghai Shangyao Cross Linked Pharmaceutical Technology Co Ltd view
CXSL2300427 重组抗CD20人源化单克隆抗体皮下注射液 Recombinant anti-CD20 humanized monoclonal antibody Injection Biological Products(1) New Drug Application 2023-06-22 Shanghai Shangyao Cross Linked Pharmaceutical Technology Co Ltd view
CXSL2200277 重组抗CD20人源化单克隆抗体皮下注射液 Recombinant anti-CD20 humanized monoclonal antibody Injection Biological Products(1) New Drug Application 2022-06-16 Shanghai Shangyao Cross Linked Pharmaceutical Technology Co Ltd view
CXSL2000334 重组抗CD20人源化单克隆抗体皮下注射液 Recombinant anti-CD20 humanized monoclonal antibody Injection Biological Products(1) New Drug Application 2020-11-28 上海交联药物研发有限公司 Shanghai Shangyao Cross Linked Pharmaceutical Technology Co Ltd In Review 2020-11-27 view